French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU
April 22, 2021 at 07:45 AM EDT
Study will compare how immune systems respond to Valneva’s vaccine candidate with the one jointly developed by AstraZeneca and the University of Oxford.